Chronic kidney disease (CKD) affects up to 3 million people in the UK. Although there is no cure, treatments can help relieve symptoms, slow or prevent progression of the condition and reduce the risk of developing related conditions such as heart disease or stroke.
Research helps further understanding of kidney disease and its causes, in addition to finding better treatments and management options. Through advances in knowledge, patients with kidney disease can live longer healthier lives.
Salford Royal is one of the major sites in the UK for renal care and research, and the renal department’s Professor Philip Kalra has a national lead role for renal trials.
The majority of renal consultants at Salford Royal are involved in research and they treat patients from Salford, Rochdale, Oldham, Bury, Bolton, Wigan and parts of Trafford, with patients able to receive dialysis at Salford, Oldham, Rochdale, Bolton and Wigan. The Trust also collaborates with other health organisations on research, including Manchester Royal Infirmary where kidney transplantations take place.
Salford Royal is also the home of the CRISIS (Chronic Renal Insufficiency Standards Implementation Study) project, which has one of the largest patient chronic kidney disease cohorts in the world. The study, which started in 2002, highlights the risk factors associated with more rapid progression of chronic kidney disease and so helps target people at greater risk for higher level care. Around 300 patients a year join the study, which has its own biobank containing 35,000 separate samples to help researchers carry out their work.
How to contact the Vascular Research Team:
Phone 0161 206 2018